The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
Abstract
Guidelines for clinical practice are aimed to indicate preferred approaches to medical problems as established by scientifically valid research. Double-blind placebo controlled studies are preferable, but compassionate-use reports and expert review articles are used in a thorough review of the literature conducted through Medline with the National Library of Medicine. When only data that will not withstand objective scrutiny are available, a recommendation is identified as a consensus of experts. Guidelines are applicable to all physicians who address the subject regardless of specialty training or interests and are aimed to indicate the preferable but not necessarily the only acceptable approach to a specific problem. Guidelines are intended to be flexible and must be distinguished from standards of care, which are inflexible and rarely violated. Given the wide range of specifics in any health-care problem, the physician must always choose the course best suited to the individual patient and the variables in existence at the moment of decision. Guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee and approved by the board of trustees. Each has been intensely reviewed and revised by the Committee, other experts in the field, physicians who will use them, and specialists in the science of decision analysis. The recommendations of each guideline are therefore considered valid at the time of composition based on the data available. New developments in medical research and practice pertinent to each guideline will be reviewed at a time established and indicated at publication to assure continued validity. The recommendations made are based on the level of evidence found. Grade A recommendations imply that there is consistent level 1 evidence (randomized controlled trials), grade B indicates that the evidence would be level 2 or 3, which are cohort studies or case-control studies. Grade C recommendations are based on level 4 studies, meaning case series or poor-quality cohort studies, and grade D recommendations are based on level 5 evidence, meaning expert opinion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–326 of 326
The fate of low grade dysplasia in ulcerative colitis
Ullman, T. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)03966-7 · Cited by 158
An Oral Preparation of Mesalamine as Long-Term Maintenance Therapy for Ulcerative Colitis
Hanauer, S. B., Sninsky, C. A., Robinson, M., Powers, B. J., McHattie, J. D., Mayle, J. E., Elson, C. O., DeMicco, M. P., Butt, J. H., Pruitt, R. E., et al. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-2-199601150-00003 · Cited by 155
Sugita, A., Sachar, D. B., Bodian, C., Ribeiro, M. B., Aufses, A. H., & Greenstein, A. J. (1991) · Gut · doi:10.1136/gut.32.2.167 · Cited by 154
Self-citationEndoscopy in inflammatory bowel disease: Indications, surveillance, and use in clinical practice
Fefferman, D. S., & Farrell, R. J. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00441-0 · Cited by 153
Sheth, S. G., & LaMont, J. T. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10475-5 · Cited by 152
Nguyen, G. C., Tuskey, A. G., Dassopoulos, T., Harris, M. L., & Brant, S. R. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20250 · Cited by 151
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential*1
Broomé, U. (1995) · Hepatology · doi:10.1016/0270-9139(95)90144-2 · Cited by 150
Levine, D. S., Riff, D. S., Pruitt, R. E., Wruble, L. D., Koval, G., Sales, D. J., Bell, J. K., & Johnson, L. K. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05781.x · Cited by 149
McGuire, B. B., Brannigan, A. E., & O’Connell, P. R. (2007) · British journal of surgery · doi:10.1002/bjs.5866 · Cited by 144
Lees, C. W., Heys, D., Ho, G., Noble, C. L., Shand, A. G., Mowat, C., Boulton-Jones, R., WILLIAMS, A., Church, N. G., Satsangi, J., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03383.x · Cited by 140
Jess, T., Loftus, E. V., Velayos, F. S., Winther, K. V., Tremaine, W. J., Zinsmeister, A. R., Harmsen, W. S., Langholz, E., Binder, V., Munkholm, P., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01070.x · Cited by 140
Ben‐Horin, S., Margalit, M., Bossuyt, P. J., Maul, J., Shapira, Y., Bojic, D., Chermesh, I., Al‐Rifai, A., Schoepfer, A. M., Bosani, M., et al. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.031 · Cited by 139
Ullman, T. A., Odze, R. D., & Farraye, F. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20766 · Cited by 139
Hurlstone, D. P., McAlindon, M. E., Sanders, D. S., Keogh, R. J., Lobo, A., & Cross, S. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.05.021 · Cited by 139
Biddle, W. L., Greenberger, N. J., Swan, J. T., McPhee, M. S., & Miner, P. B. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90569-0 · Cited by 138
Hazard rates for dysplasia and cancer in ulcerative colitis: Results from a surveillance program
Lashner, B. A., Silverstein, M. D., & Hanauer, S. B. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01537106 · Cited by 138
Risk of colorectal neoplasia in patients with primary sclerosing cholangitis
Loftus, E. V., Sandborn, W., Tremaine, W., Mahoney, D., Zinsmeister, A., Offord, K., & Melton, L. J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566590 · Cited by 136
Pentasa UC Maintenance Study Group, Miner, P. B., Hanauer, S. B., ROBINSON, M. G., Schwartz, J., & Arora, S. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065413 · Cited by 135
Schluender, S. J., Ippoliti, A., Dubinsky, M. C., Vasiliauskas, E. A., Papadakis, K. A., Mei, L., Targan, S. R., & Fleshner, P. R. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9008-3 · Cited by 135
Clinical guidelines for the management of pouchitis
Pardi, D. S., D’Haens, G., Shen, B., Campbell, S. S., & Gionchetti, P. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21039 · Cited by 130
Regueiro, M. D., Loftus, E. V., Steinhart, H., & Cohen, R. D. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000231495.92013.5e · Cited by 128
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
de Boer, N. K. H., Bodegraven, A. A. V., Jharap, B., de Graaf, P., & Mulder, C. J. J. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1000 · Cited by 128
Singh, H., Demers, A. A., Nugent, Z. J., Mahmud, S. M., Kliewer, E. V., & Bernstein, C. N. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.021 · Cited by 127
Alvès, A., Panis, Y. H., Bouhnik, Y., Maylin, V., Lavergne‐Slove, A., & Valleur, P. D. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00434-4 · Cited by 127
Cassinotti, A., Actis, G. C., Duca, P., Massari, A., Colombo, E. M., Gai, E., Annese, V., D'Albasio, G., Manes, G., Travis, S. P. L., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.410 · Cited by 125
Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications
Hyde, G. M., Jewell, D. P., Kettlewell, M. G. W., & Mortensen, N. J. M. C. (2001) · Diseases of the Colon & Rectum · doi:10.1007/bf02234594 · Cited by 125
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
Dew, M. J., Hughes, P., Harries, A. D., Williams, G., Evans, B. K., & Rhodes, J. (1982) · BMJ · doi:10.1136/bmj.285.6347.1012 · Cited by 125
Adverse Events Associated With the Use of Cyclosporine in Patients With Inflammatory Bowel Disease
Sternthal, M., Murphy, S., George, J. M., Kornbluth, A. A., Lichtiger, S., & Present, D. H. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01718.x · Cited by 125
Self-citationHigh-Dose Methylprednisolone in the Treatment of Active Ulcerative Colitis
Rosenberg, W. M., Ireland, A., & Jewell, D. P. (1990) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199002000-00011 · Cited by 124
Irving, P. M., & Gibson, P. R. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1004 · Cited by 122
Is Endoscopy Necessary for the Measurement of Disease Activity in Ulcerative Colitis?
Higgins, P., Schwartz, M. B., Mapili, J., & Zimmermann, E. M. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40641.x · Cited by 122
Lindberg, B. U., Broomé, U., & Persson, B. (2001) · Diseases of the Colon & Rectum · doi:10.1007/bf02234825 · Cited by 120
Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment?
Jones, J., & Loftus, E. V. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20211 · Cited by 120
Mulder, C. J. J., Tytgat, G. N. J., Weterman, I. T., Dekker, W., Blok, P., Schrijver, M., & van der Heide, H. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80061-1 · Cited by 120
Pruitt, R. E., Hanson, J., Safdi, M. A., Wruble, L. D., Hardi, R., Johanson, J. F., Koval, G., Riff, D. S., Winston, B., Cross, A. J., et al. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07103.x · Cited by 120
Utility of serological markers in inflammatory bowel diseases: Gadget or magic?
Papp, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i14.2028 · Cited by 119
Bernstein, C. N., Nugent, Z., Longobardi, T., & Blanchard, J. F. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.417 · Cited by 118
Systematic review: the management of pouchitis
Pardi, D. S., & Sandborn, W. J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02884.x · Cited by 118
Isaacs, K. L., Sandler, R. S., Abreu, M. T., Picco, M. F., Hanauer, S. B., Bickston, S. J., Present, D. H., Farraye, F. A., Wolf, D. C., & Sandborn, W. J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20187 · Cited by 118
Abnormalities of uterine cervix in women with inflammatory bowel disease
Bhatia, J. K. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i38.6167 · Cited by 116
Gross Versus Microscopic Pancolitis and the Occurrence of Neoplasia in Ulcerative Colitis
Mathy, C., Schneider, K., Chen, Y., Varma, M. G., Terdiman, J. P., & Mahadevan, U. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200311000-00002 · Cited by 114
Kruis, W., Schreiber, S., Theuer, D., Brandes, J.-W., Schütz, E., Howaldt, S., Krakamp, B., Hämling, J., Mönnikes, H., Koop, I., et al. (2001) · Gut · doi:10.1136/gut.49.6.783 · Cited by 112
Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth.
Dew, M. J., Harries, A. D., Evans, N., Evans, B. K., & Rhodes, J. (1983) · BMJ · doi:10.1136/bmj.287.6384.23 · Cited by 111
Bernstein, C. N., Blanchard, J., Metge, C. J., & Yogendran, M. S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.08718.x · Cited by 111
Melmed, G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20943 · Cited by 111
(2003) · Gastroenterology · doi:10.1053/gast.2003.50107 · Cited by 111
Possible Association Between Isotretinoin and Inflammatory Bowel Disease
Reddy, D., Siegel, C. A., Sands, B. E., & Kane, S. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00632.x · Cited by 110
Serious Adverse Events With Infliximab: Analysis of Spontaneously Reported Adverse Events
Hansen, R. A., Gartlehner, G., Powell, G. E., & Sandler, R. S. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.02.016 · Cited by 108
Theis, V., & Rhodes, J. M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03553.x · Cited by 108
Hepatotoxicity of 6-Mercaptopurine (6-MP) and Azathioprine (AZA) in Adult IBD Patients
Shaye, O. A., Yadegari, M., Abreu, M. T., Poordad, F. F., Simon, K., Martin, P., Papadakis, K. A., Ippoliti, A., Vasiliauskas, E., & Tran, T. T. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01515.x · Cited by 105
Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment
Vieth, M., Behrens, H., & Stolte, M. (2006) · Gut · doi:10.1136/gut.2005.075531 · Cited by 105
Fockens, P., Mulder, C. J. J., Tytgat, G. N. J., Blok, P., & Ferwerda, J. (1995) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199511000-00003 · Cited by 103
Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease
Barrie, A. M., & Regueiro, M. D. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20196 · Cited by 102
Long-Term Use of Mesalamine (Rowasa) Suppositories in Remission Maintenance of Ulcerative Proctitis
Hanauer, S. B., Good, L. I., Goodman, M. W., Pizinger, R. J., Strum, W. B., Lyss, C., Haber, G. B., Williams, N. C., & ROBINSON, M. G. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02185.x · Cited by 102
Prevention and Treatment of Osteoporosis in Patients With Inflammatory Bowel Disease
Valentine, J. F., & Sninsky, C. A. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00036-2 · Cited by 102
Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis
Cacheux, W., Seksik, P., Lémann, M., Marteau, P. R., Nion–Larmurier, I., Afchain, P., Daniel, F. E., Beaugerie, L., & Cosnes, J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01653.x · Cited by 100
Nuako, K. W., Ahlquist, D. A., Sandborn, W. J., Mahoney, D. W., Siems, D. M., & Zinsmeister, A. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980301)82:5<822::aid-cncr4>3.0.co;2-l · Cited by 99
Small bowel gas in severe ulcerative colitis.
Chew, C. N., Nolan, D. J., & Jewell, D. P. (1991) · Gut · doi:10.1136/gut.32.12.1535 · Cited by 99
Predictors of Pouchitis after Ileal Pouch-Anal Anastomosis: A Retrospective Review
Hoda, K. M., Collins, J. F., Knigge, K. L., & Deveney, K. E. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9194-7 · Cited by 99
Actis, G. C., Fadda, M., David, E., & Sapino, A. (2007) · BMC Gastroenterology · doi:10.1186/1471-230x-7-13 · Cited by 99
Prevention and treatment of osteoporosis in inflammatory bowel disease
Lichtenstein, G. R., Sands, B. E., & Pazianas, M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200608000-00016 · Cited by 98
Herrinton, L. J., Liu, L., Lafata, J. E., Allison, J. E., Andrade, S. E., Korner, E. J., Chan, K. A., Platt, R. G., Hiatt, D. C., & O’Connor, S. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20021 · Cited by 98
García‐Vidal, C., Fernández, S. R., Teijón, S., Esteve, M., Rodríguez‐Carballeira, M., Lacasa, J., Salvador, G., & Garau, J. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0628-x · Cited by 96
Lees, C. W., MAAN, A. K., Hansoti, B., Satsangi, J., & Arnott, I. D. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03570.x · Cited by 96
Urgent Subtotal Colectomy for Severe Inflammatory Bowel Disease
Hyman, N., Cataldo, P. A., & Osler, T. M. (2004) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-0750-5 · Cited by 96
Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis
Das, P., Johnson, M. W., Tekkis, P. P., & Nicholls, R. J. (2006) · Colorectal Disease · doi:10.1111/j.1463-1318.2006.01148.x · Cited by 94
MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE
Stein, R. B., & Hanauer, S. B. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70058-3 · Cited by 94
Benson, A., Barrett, T. A., Sparberg, M. S., & Buchman, A. L. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20263 · Cited by 91
Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis
Kamm, M. A., Lichtenstein, G. R., Sandborn, W. J., Schreiber, S., Lees, K., Barrett, K., & Joseph, R. E. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20580 · Cited by 90
Sandborn, W. J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00115-x · Cited by 88
Hanauer, S. B., & (For the U.S. PENTASA Enema Study Group) (1998) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199805000-00001 · Cited by 88
Male sexual function improves after ileal pouch anal anastomosis
Görgün, E., Remzi, F. H., D, D. K. M. M., Connor, J. T., O’Brien, K. M., Loparo, B., & Fazio, V. W. (2005) · Colorectal Disease · doi:10.1111/j.1463-1318.2005.00895.x · Cited by 87
Ireland, A., Mason, C., & Jewell, D. P. (1988) · Gut · doi:10.1136/gut.29.6.835 · Cited by 87
Rowe, F. A., Walker, J. H., Karp, L. C., Vasiliauskas, E. A., Plevy, S. E., & Targan, S. R. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02186.x · Cited by 86
Patterns of Colonic Involvement at Initial Presentation in Ulcerative Colitis
Robert, M. E., Skacel, M., Ullman, T. A., Bernstein, C. N., Easley, K. A., & Goldblum, J. R. (2004) · American Journal of Clinical Pathology · doi:10.1309/xlxkj84c3jcw3rch · Cited by 85
Holtmann, M. H., Krummenauer, F., Claas, C., Kremeyer, K., Lorenz, D., Rainer, O., Vogel, I., Böcker, U., Böhm, S. K., Büning, C., et al. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-9037-5 · Cited by 84
Matzen, P. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529108998618 · Cited by 84
McIntyre, P. B., Rodrigues, C. A., Lennard‐Jones, J. E., Barrison, I. G., Walker, J., Baron, J. H., & THORNTON, P. C. (1988) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1988.tb00693.x · Cited by 83
GI distension in severe ulcerative colitis
Latella, G., Vernia, P., Viscido, A., Frieri, G., Cadau, G., Cocco, A., Cossu, A., Tomei, E., & Caprilli, R. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04047-9 · Cited by 83
The role of azathioprine in the management of ulcerative colitis
Lobo, A., Foster, P. N., Burke, D., Johnston, D. A., & Axon, A. T. R. (1990) · Diseases of the Colon & Rectum · doi:10.1007/bf02156261 · Cited by 83
Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy
D’Ovidio, V., Vernia, P., Gentile, G., Capobianchi, A., Marcheggiano, A., Viscido, A., Martino, P., & Caprilli, R. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2008.06.002 · Cited by 83
Cangemi, J. R., Wiesner, R. H., Beaver, S. J., Ludwig, J., MacCarty, R. L., Dozois, R. R., Zinsmeister, A. R., & LaRusso, N. F. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80078-2 · Cited by 82
Prantera, C., Kohn, A., Campieri, M., Caprilli, R., Cottone, M., Pallone, F., Savarino, V., Sturniolo, G. C., Vecchi, M. L., Ardia, A., et al. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04117.x · Cited by 81
General health maintenance in IBD
Moscandrew, M. E., Mahadevan, U., & Kane, S. V. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20944 · Cited by 80
Rutgeerts, P. J. (1989) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1989.tb00204.x · Cited by 79
Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study.
Rao, S. S., Dundas, S. A. C., Holdsworth, C. D., Cann, P. A., Palmer, K. R., & Corbett, C. L. (1989) · Gut · doi:10.1136/gut.30.5.675 · Cited by 79
Meta-Analysis of Risk of Malignancy with Immunosuppressive Drugs in Inflammatory Bowel Disease
増永, ゆ., Ohno, K., Ogawa, R., Hashiguchi, M., Echizen, H., & Ogata, H. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h219 · Cited by 78
Performing a Cost-Effectiveness Analysis: Surveillance of Patients With Ulcerative Colitis
Provenzale, D., Wong, J. B., Onken, J. E., & Lipscomb, J. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00314.x · Cited by 77
The Nature of Inflammatory Bowel Disease in Patients With Coexistent Colonic Diverticulosis
Sultan, K. S., Fields, S. W., Panagopoulos, G., & Korelitz, B. I. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000210095.44123.6d · Cited by 75
Optimum dose of olsalazine for maintaining remission in ulcerative colitis.
Travis, S. P. L., Tysk, C., de Silva, H. J., Sandberg–Gertzén, H., Jewell, D. P., & Järnerot, G. (1994) · Gut · doi:10.1136/gut.35.9.1282 · Cited by 74
D’Arienzo, A., Panarese, A., D’Armiento, F. P., Lancia, C., Quattrone, P., Giannattasio, F., Boscaino, A., & Mazzacca, G. (1990) · PubMed · Cited by 73
Non-IBD and noninfectious colitis
Nielsen, O. H., Vainer, B., & Rask-Madsen, J. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1005 · Cited by 70
Kornbluth, A. A., Hayes, M., Feldman, S., Hunt, M., Fried-Boxt, E., Lichtiger, S., Legnani, P. E., George, J. M., & Young, J. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00571.x · Cited by 68
Self-citationTumor Necrosis Factor Blockers and Reactivation of Latent Tuberculosis
Keane, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421499 · Cited by 67
D'Albasio, G., Paoluzi, O. A., Campieri, M., Porro, B. G., Pera, A., Prantera, C., Sturniolo, G. C., & Miglioli, M. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.228_a.x · Cited by 67
The “Natural History” of Ulcerative Colitis
Meyers, S., & Janowitz, H. D. (1989) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198902000-00008 · Cited by 66
Gisbert, J. P., Niño, P., Cara, C., & Rodrigo, L. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03732.x · Cited by 65
The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis
Ricketts, R. R. (1991) · Journal of Pediatric Surgery · doi:10.1016/0022-3468(91)90199-4 · Cited by 64
Clinical features and management of primary sclerosing Cholangitis
Silveira, M. G., & Lindor, K. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3338 · Cited by 64
D'Albasio, G., Trallori, G., Ghetti, A., Milla, M., Nucci, A., Pacini, F., & Morettini, A. (1990) · Diseases of the Colon & Rectum · doi:10.1007/bf02156265 · Cited by 64
Segmental Colitis Associated With Diverticular Disease and Other IBD Look-alikes
Harpaz, N., & Sachar, D. B. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225505.67547.90 · Cited by 63
Self-citationMicroalbuminuria in inflammatory bowel disease.
Mahmud, N., Stinson, J. C., O'Connell, M. A., Mantle, T. J., Keeling, P. W. N., Feely, J., Weir, D. G., & Kelleher, D. P. (1994) · Gut · doi:10.1136/gut.35.11.1599 · Cited by 61
Lichtenstein, G. R., Kamm, M. A., Sandborn, W. J., Lyne, A., & JOSEPH, R. E. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03688.x · Cited by 58
D'Albasio, G., Paoluzi, O. A., Campieri, M., PORRO, G., Pera, A., Prantera, C., Sturniolo, G. C., Miglioli, M., & THEITALIANIBDSTUDYGROUP (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00108-7 · Cited by 56
Cangemi, J. R., Wiesner, R. H., Beaver, S. J., Ludwig, J., MacCarty, R. L., Dozois, R. R., Zinsmeister, A. R., & LaRusso, N. F. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90903-7 · Cited by 56
Diagnosis of Colitis: Making the Initial Diagnosis
Abreu, M. T., & Harpaz, N. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.032 · Cited by 54
Loftus, E. V., Delgado, D. J., Friedman, H. S., & Sandborn, W. J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01867.x · Cited by 53
ALMs versus DALMs in ulcerative colitis: Polypectomy or colectomy?
Bernstein, C. N. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70300-8 · Cited by 53
Recommended Adult Immunization Schedule: United States, 2009
Advisory Committee on Immunization Practices† (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-1-200901060-00008 · Cited by 53
Kiilerich, S., Ladefoged, K., Rannem, T., & Ranløv, P. (1992) · Gut · doi:10.1136/gut.33.2.252 · Cited by 51
Isotretinoin and intestinal inflammation: what gastroenterologists need to know
Shale, M., Kaplan, G. G., Panaccione, R., & Ghosh, S. K. (2009) · Gut · doi:10.1136/gut.2008.170530 · Cited by 47
Autoimmune hemolytic anemia in ulcerative colitis
Altman, A. R., Maltz, C., & Janowitz, H. D. (1979) · Digestive Diseases and Sciences · doi:10.1007/bf01296541 · Cited by 46
Multiple Organ Dysfunction in Ulcerative Colitis
Caprilli, R., Latella, G., Vernia, P., & Frieri, G. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00811-x · Cited by 46
Maintenance Therapy in Ulcerative Colitis and Crohnʼs Disease
Sachar, D. B. (1995) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199503000-00009 · Cited by 46
Self-citationSuboptimal Rates of Cervical Testing Among Women With Inflammatory Bowel Disease
Long, M. D., Porter, C. Q., Sandler, R. S., & Kappelman, M. D. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.10.007 · Cited by 45
Exposing the Weaknesses: A Systematic Review of Azathioprine Efficacy in Ulcerative Colitis
Leung, Y., Panaccione, R., Hemmelgarn, B. R., & Jones, J. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0036-6 · Cited by 41
Endoscopic evaluation of patients with inflammatory bowel disease
Simpson, P. A., & Papadakis, K. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20398 · Cited by 37
Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis
Pardi, D. S., & Shen, B. (2008) · Endoscopy · doi:10.1055/s-2007-995784 · Cited by 34
Hu, M. Y., Maroo, S., Kyne, L., Cloud, J. W., Tummala, S., Katchar, K., Dreisbach, V. C., Noddin, L., & Kelly, C. P. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.06.024 · Cited by 31
Is thiopurine therapy in ulcerative colitis as effective as in Crohn’s disease?: Table 1
Ghosh, S. K., Chaudhary, R., Carpani, M., & Playford, R. J. (2005) · Gut · doi:10.1136/gut.2005.074401 · Cited by 31
Abitbol, V., Briot, K., Roux, C., Roy, C., Seksik, P., Charachon, A., Bouhnik, Y., Coffin, B., Allez, M., Lamarque, D., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.016 · Cited by 27
KOHIGASHI, K., Fukuda, Y., & Imura, H. (1987) · Gastroenterologia Japonica · doi:10.1007/bf02774258 · Cited by 25
Row replacement algorithms for screen editors
Meyers, E. W., & Miller, W. (1989) · ACM Transactions on Programming Languages and Systems · doi:10.1145/59287.59290 · Cited by 21
Therapy Insight: osteoporosis in inflammatory bowel disease—advances and retreats
Bernstein, C. N., & Leslie, W. D. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0169 · Cited by 18
Implementation of Colon Cancer Screening: Techniques, Costs, and Barriers
Miller, A. B. (2008) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.12.015 · Cited by 13
Neoplastic and other complications of inflammatory bowel disease
Bernstein, C. N. (2000) · Current Gastroenterology Reports · doi:10.1007/s11894-000-0007-y · Cited by 7
Cited by
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Self-citationLamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60150-0 · Cited by 2,078
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920
Metadata
- Authors
- Kornbluth, A., & Sachar, D. B.
- Venue
- American Journal of Gastroenterology
- Published
- 2010-03
- Volume
- 105
- Issue
- 3
- Pages
- 501-523
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W4295333203
- Cited by
- 2,023
- References
- 326
- FWCI
- 71.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.